Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects

Clinical trial NCT06654960 · COMPLETED

Trial details

NCT number: NCT06654960
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-11-05
Primary completion: 2024-12-26
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.